"Indomethacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.
| Descriptor ID |
D007213
|
| MeSH Number(s) |
D03.633.100.473.420
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Indomethacin".
Below are MeSH descriptors whose meaning is more specific than "Indomethacin".
This graph shows the total number of publications written about "Indomethacin" by people in this website by year, and whether "Indomethacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2017 | 3 | 4 | 7 |
| 2018 | 2 | 0 | 2 |
| 2019 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Indomethacin" by people in Profiles.
-
Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization. Molecules. 2021 Jun 21; 26(12).
-
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2. Viruses. 2021 03 26; 13(4).
-
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19. Int J Clin Pract. 2020 Sep; 74(9):e13535.
-
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2. J Pharmacokinet Pharmacodyn. 2020 06; 47(3):189-198.
-
Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial. Endoscopy. 2019 10; 51(10):915-921.
-
Regulation of YAP by Mammalian Target of Rapamycin Complex 1 in Endothelial Cells Controls Blood Pressure Through COX-2/mPGES-1/PGE2 Cascade. Hypertension. 2019 10; 74(4):936-946.
-
Role of NO and other vascular mediators in the etiopathogenesis of necrotizing enterocolitis. Front Biosci (Schol Ed). 2019 03 01; 11(1):9-28.
-
Protective effects of triple fermented barley extract (FBe) on indomethacin-induced gastric mucosal damage in rats. BMC Complement Altern Med. 2019 Feb 20; 19(1):49.
-
Urinary acute kidney injury biomarkers in very low-birth-weight infants on indomethacin for patent ductus arteriosus. Pediatr Res. 2019 04; 85(5):678-686.
-
Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates. J Matern Fetal Neonatal Med. 2020 Feb; 33(4):645-650.